Whole blood platelet aggregometry and platelet function testing

Seminars in Thrombosis and Hemostasis

Volumn 35, Issue 2, 2009, Pages 168-180

  McGlasson, David L ^a,c   Fritsma, George A ^b  

^a WILFORD HALL MEDICAL CENTER   (United States)

^b University of Alabama at Birmingham   (United States)

^c Building 4430 ^*  (United States)

Author keywords

Agonist; Antiplatelet therapy; Aspirin resistance; Aspirin like disorder; Impedance based whole blood aggregometry; Lumiaggregometry; Platelet metabolic pathway defects; Platelet plasma membrane defects; Platelet secretion defects; Storage pool disorder; Thienopyridine resistance; Von Willebrand disease

Indexed keywords

ACETYLSALICYLIC ACID; ADENOSINE DIPHOSPHATE; ARACHIDONIC ACID; CLOPIDOGREL; COLLAGEN; DIPYRIDAMOLE; RISTOCETIN; THROMBIN;

BERNARD SOULIER DISEASE; BLOOD; CARDIOPULMONARY BYPASS; CELL AGGREGATION; CHEDIAK HIGASHI SYNDROME; DIAGNOSTIC PROCEDURE; DIAGNOSTIC TEST; DRUG EFFECT; DRUG RESPONSE; DRUG SENSITIVITY; GLANZMANN DISEASE; HUMAN; HYPERLIPIDEMIA; ISCHEMIC HEART DISEASE; LOADING DRUG DOSE; OCULAR ALBINISM; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE DISORDER; THROMBOCYTE FUNCTION; THROMBOSIS; WHOLE BLOOD PLATELET AGGREGOMETRY; WISKOTT ALDRICH SYNDROME; BLOOD CLOTTING PARAMETERS; METHODOLOGY; PHYSIOLOGY; THROMBOCYTE;

BLOOD PLATELET DISORDERS; BLOOD PLATELETS; HUMANS; PLATELET AGGREGATION; PLATELET FUNCTION TESTS;

EID: 67349259136     PISSN: 00946176     EISSN: 10989064     Source Type: Journal    
DOI: 10.1055/s-0029-1220325     Document Type: Review

References (93)

1. Jacobs K. Platelet function testing. Advance 1999:56-59
2. Fritsma G. An overview of clinical laboratory hematology. In: Rodak BF, Fritsma GA, Doig K, eds. Hematology: Clinical Principles and Applications. St. Louis, MI: Elsevier; 2007:1-6
3. Born GVR. Quantitative investigations into the aggregation of blood platelets. J Physiol 1962;162:67-68
4. Born GV, Cross MJ. The aggregation of blood platelets. J Physiol 1963;168:178-195
5. Harrison P, Mumford A. Screening tests of platelet function: update on their appropriate uses for diagnostic testing. Semin Thromb Hemost 2009;35:150-157
6. Cattaneo M. Light transmission aggregometry and ATP release for the diagnostic assessment of platelet function. Semin Thromb Hemost 2009;35:158-167
7. Cardinal DC, Flower RJ. The electronic aggregometer: a novel device for assessing platelet behavior in blood. J Pharmacol Methods 1980;3(2):135-158
8. Ingerman-Wojenski CM, Silver MJ. A quick method for screening platelet dysfunctions using the whole blood lumi-aggregometer. Thromb Haemost 1984;51:154-156 (Pubitemid 14145084)
9. Linnemann B, Schwonberg J, Mani H, Prochnow S, Lindhoff-Last E. Standardization of light transmittance aggregometry for monitoring antiplatelet therapy: an adjustment for platelet count is not necessary. J Thromb Haemost 2008;6:677-683
10. Ciruela F. Fluorescence-based methods in the study of protein-protein interactions in living cells. CurrOpin Biotechnol 2008;19:338-343
11. Viviani VR. The origin, diversity, and structure function relationships of insect luciferases. Cell Mol Life Sci 2002;59:1833-1850
12. Feinman RD, Detwiler TC, Ingerman-Wojenski C. The lumi-aggregometer as a research and clinical tool. In: Longenecker GL, ed. The Platelets; Physiology and Pharmacology. New York, NY: Academic Press; 1985:429-440
13. Blackwell GJ, Flower RJ, Russell-Smith N, et al. Prostacyclin is produced in whole blood. Br J Pharmacol 1978;64:436
14. Sweeney JD, Labuzetta JW, Fitzpatrick JE. The effect of the platelet count on the aggregation response and adenosine triphosphate release in an impedance lumi-aggregometer. Am J Clin Pathol 1988;89:655-659
15. Dyszkiewicz-Korpanty AM, Frenkel EP, Sarode R. Approach to the assessment of platelet function: comparison between optical-based platelet-rich plasma and impedance-based whole blood platelet aggregation methods. Clin Appl Thromb Hemost 2005;11:25-35 (Pubitemid 40194195)
16. Sweeney JD, Hoernig LA, Michnik A, Fitzpatrick JE. Whole blood aggregometry. Influence of sample collection and delay in study performance on test results. Am J Clin Pathol 1989;92:676-679 (Pubitemid 19272886)
17. Christie DJ, Avari T, Carrington LR, et al. Platelet Function Testing by Aggregometry; Approved Guideline. CLSI document H58-A. Wayne, PA: Clinical and Laboratory Standards Institute (CLSI); 2008
18. Brace LD. Qualitative disorders of platelets and vasculature. In: Rodak BF, Fritsma GA, Doig K, eds. Hematology: Clinical Principles and Applications, 3rd ed. New York, NY: Elsevier; 2007:654-669
19. Nurden AT, George JN. Inherited abnormalities of the platelet membrane: Glanzmann thrombasthenia, Bernard- Soulier syndrome, and other disorders. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice, 5th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:987-1010
20. Geddis AE, Kaushansky K. Inherited thrombocytopenias: toward a better molecular understanding of disorders of platelet production. Curr Opin Pediatr 2004;16:15-22 (Pubitemid 38168156)
21. Peerschke EI, Zucker MB, Grant RA, Egan JJ, Johnson MM. Correlation between fibrinogen binding to human platelets and platelet aggregability. Blood 1980;55:841-847 (Pubitemid 10095994)
22. Nurden A, Fiore M, Pillois X, Nurden P. Genetic testing in the diagnostic evaluation of inherited platelet disorders. Semin Thromb Hemost 2009;35:204-212
23. Fritsma GA. Tests of platelet number and function. In: Corriveau DM, Fritsma GA, eds.Hemostasis and Thrombosis in the Clinical Laboratory. Philadelphia, PA: Lippincott; 1988:278-302
24. Nieuwenhuis HK, Akkerman JW, Houdijk WPM, Sixma JJ. Human blood platelets showing no response to collagen fail to express surface glycoprotein Ia. Nature 1985;318:470-472
25. Deckmyn H, Chew SL, Vermylen J. Lack of platelet response to collagen associated with an autoantibody against glycoprotein Ia: a novel cause of acquired qualitative platelet dysfunction. Thromb Haemost 1990;64:74-79 (Pubitemid 20301853)
26. Cattaneo M. Inherited platelet-based bleeding disorders. J Thromb Haemost 2003;1:1628-1636
27. Gachet C. ADP receptors of platelets and their inhibition. Thromb Haemost 2001;86:222-232 (Pubitemid 32663953)
28. Hirata T, Ushikubi F, Kakizuka A, Okuma M, Narumiya S. Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation. J Clin Invest 1996; 97:949-956 (Pubitemid 26070574)
29. Higuchi W, Fuse I, Hattori A, Aizawa Y. Mutations of the platelet thromboxane A2 (TXA2) receptor in patients characterized by the absence of TXA2-induced platelet aggregation despite normal TXA2 binding activity. Thromb Haemost 1999;82:1528-1531 (Pubitemid 29527650)
30. Rao AK, Willis J, Kowalska MA, Wachtfogel YT, Colman RW. Differential requirements for platelet aggregation and inhibition of adenylate cyclase by epinephrine. Studies of a familial platelet alpha 2-adrenergic receptor defect. Blood 1988;71:494-501
31. Meyer M, Kirchmaier CM, Schirmer A, Spangenberg P, Ströhl C, Breddin K. Acquired disorder of platelet function associated with autoantibodies against membrane glycoprotein IIb-IIIa complex - 1. Glycoprotein analysis. Thromb Haemost 1991;65:491-496
32. Campo G, Valgimigli M, Gemmati D. Value of platelet reactivity in predicting response to treatment and clinical outcome in patients undergoing primary coronary intervention: insights into the STRATEGY Study. J Am Coll Cardiol 2006;48:2178-2185 (Pubitemid 44873056)
33. Nurden AT. Qualitative disorders of platelets and megakaryocytes. J Thromb Haemost 2005;3:1773-1782
34. Rao AK. Hereditary disorders of platelet secretion and signal transduction. In: Colman RW, Marder VJ, Clowes AW, George JN, Goldhaber SZ, eds. Hemostasis and Thrombosis: Basic Principles and Clinical Practice. Philadelphia, PA: Lippincott Williams & Wilkins; 2006:961-974
35. Rao AK, Koike K, Willis J, et al. Platelet secretion defect associated with impaired liberation of arachidonic acid and normal myosin light chain phosphorylation. Blood 1984;64:914-921 (Pubitemid 14003615)
36. Pereira J, Quiroga T, Mezzano D. Laboratory assessment of familial, nonthrombocytopenic mucocutaneous bleeding: a definitive diagnosis is often not possible. Semin Thromb Hemost 2008;34:654-662
37. Poston RS, Gu J, White C, et al. Perioperative management of aspirin resistance after off-pump coronary artery bypass grafting: possible role for aprotinin. Transfusion 2008;48(1, Suppl):39S-46S (Pubitemid 351643119)
38. Mascelli MA, Worley S, Veriabo NJ, et al. Rapid assessment of platelet function with a modified whole-blood aggregometer in percutaneous transluminal coronary angioplasty patients receiving anti-GP IIb/IIIa therapy. Circulation 1997;96:3860-3866 (Pubitemid 27506042)
39. Ivandic BT, Giannitsis E, Schlick P, Staritz P, Katus HA, Hohlfeld T. Determination of aspirin responsiveness by use of whole blood platelet aggregometry. Clin Chem 2007;53:614-619 (Pubitemid 46580230)
40. Gu J, Prastein D, Pierson R N II, et al. Aspirin resistance: an underrecognized risk factor in early vein graft thrombosis after off-pump coronary artery bypass (OPCAB). Presented at: American Heart Association meeting; November 7-10, 1994, Dallas, TX
41. Avram S, Lupu A, Angelescu S, Olteanu N, Mut-Popescu D. Abnormalities of platelet aggregation in chronic myeloproliferative disorders. J Cell Mol Med 2001;5:79-87 (Pubitemid 33772986)
42. Zeidman A, Sokolover N, Fradin Z, Cohen A, Redlich O, Mittelman M. Platelet function and its clinical significance in the myelodysplastic syndromes. Hematol J 2004;5:234-238 (Pubitemid 38931329)
43. Remold-O'Donnell E, Rosen FS, Kenney DM. Defects in Wiskott-Aldrich syndrome blood cells. Blood 1996;87:2621-2631 (Pubitemid 26102210)
44. Drachman JG. Inherited thrombocytopenia: when a low platelet count does not mean ITP. Blood 2004;103:390-398
45. Nieuwenhuis HK, Akkerman JW, Sixma JJ. Patients with a prolonged bleeding time and normal aggregation tests may have storage pool deficiency: studies on one hundred six patients. Blood 1987;70:620-623
46. Israels SJ, McNicol A, Robertson C, Gerrard JM. Platelet storage pool deficiency: diagnosis in patients with prolonged bleeding times and normal platelet aggregation. Br J Haematol 1990;75:118-121 (Pubitemid 20157990)
47. Manoharan A, Gemmell R, Brighton T, Dunkley S, Lopez K, Kyle P. Thrombosis and bleeding in myeloproliferative disorders: identification of at-risk patients with whole blood platelet aggregation studies. Br J Haematol 1999;105:618-625 (Pubitemid 29277016)
48. Manoharan A, Brighton T, Gemmell R, Lopez K, Moran S, Kyle P. Platelet dysfunction in myelodysplastic syndromes: a clinicopathological study. Int J Hematol 2002;76:272-278 (Pubitemid 43020317)
49. Manoharan A, Gemmell R, Hartwell T. Use of whole blood platelet lumi-aggregometry to optimize anti-platelet therapy in patients with chronic myeloproliferative disorders. Am J Hematol 2006;81:676-683 (Pubitemid 44306826)
50. Löfvenberg E, Nilsson TK. Qualitative platelet defects in chronic myeloproliferative disorders: evidence for reduced ATP secretion. Eur J Haematol 1989;43:435-440 (Pubitemid 20088281)
51. Girtovitis FI, Ntaios G, Papadopoulos A, Ioannidis G, Makris PE. Defective platelet aggregation in myelodysplastic syndromes. Acta Haematol 2007;118:117-122 (Pubitemid 47413796)
52. Bevan DH. Cardiac bypass haemostasis: putting blood through the mill. Br J Haematol 1999;104:208-219
53. Despotis GJ, Avidan MS, Hogue CW Jr. Mechanisms and attenuation of hemostatic activation during extracorporeal circulation. Ann Thorac Surg 2001;72:S1821-S1831
54. Whitlock R, Crowther MA, Ng HJ. Bleeding in cardiac surgery: its prevention and treatment - an evidence-based review. Crit Care Clin 2005;21:589-610 (Pubitemid 40898160)
55. Shaffer KE, Pearman DT, Galen RS, Carville DG. A rapid platelet function assay used to regulate platelet transfusion prophylaxis following cardiopulmonary bypass surgery. J Extra Corpor Technol 2004;36:145-148
56. Engelberger L, Faeh B, Berdat PA, et al. Impact of clopidogrel in coronary artery bypass grafting. Eur J Cardiothorac Surg 2004;26:96-101 (Pubitemid 38759931)
57. Friend M, Vucenik I, Miller M. Research pointers: platelet responsiveness to aspirin in patients with hyperlipidaemia. BMJ 2003;326:82-83 (Pubitemid 36092290)
58. Gresele P, Zoja C, Deckmyn H, Arnout J, Vermylen J, Verstraete M. Dipyridamole inhibits platelet aggregation in whole blood. Thromb Haemost 1983;50:852-856 (Pubitemid 14218224)
59. Gresele P, Zoja C, Deckmyn H, et al. Dipyridamole inhibits platelet aggregation in whole blood. Thromb Haemost 1983;50:852-856 (Pubitemid 14218224)
60. Nakamura T, Uchiyama S, Yamazaki M, Iwata M. Effects of dipyridamole and aspirin on shear-induced platelet aggregation in whole blood and platelet-rich plasma. Cerebrovasc Dis 2002;14:234-238 (Pubitemid 36151424)
61. Riess H, Braun G, Brehm G, Hiller E. Critical evaluation of platelet aggregation in whole human blood. Am J Clin Pathol 1986;85:50-56 (Pubitemid 16166040)
62. de la Cruz JP, Camara S, Bellido I, Carrasco T, Sanchez de la Cuesta F. Platelet aggregation in human whole blood after chronic administration of aspirin. Thromb Res 1987;46:133-140 (Pubitemid 17068375)
63. Sathiropas P, Marbet GA, Sahaphong S, Duckert F. Detection of small inhibitory effects of acetylsalicylic acid (ASA) by platelet impedance aggregometry in whole blood. Thromb Res 1988;51:55-62 (Pubitemid 18168143)
64. McKee SA, Sane DC, Deliargyris EN. Aspirin resistance in cardiovascular disease: a review of prevalence, mechanisms, and clinical significance. Thromb Haemost 2002;88:711-715
65. Lordkipanidzé M, Pharand C, Schampaert E, Turgeon J, Palisaitis DA, Diodati JG. A comparison of six major platelet function tests to determine the prevalence of aspirin resistance in patients with stable coronary artery disease. Eur Heart J 2007;28:1702-1708 (Pubitemid 47227104)
66. Dyszkiewicz-Korpanty AM, Kim A, Burner JD, Frenkel EP, Sarode R. Comparison of a rapid platelet function assay - Verify Now Aspirin - with whole blood impedance aggregometry for the detection of aspirin resistance. Thromb Res 2007;120:485-488 (Pubitemid 47094907)
67. McGlasson DL, Fritsma GA. Comparison of four laboratory methods to assess aspirin sensitivity. Blood Coagul Fibrinolysis 2008;19:120-123
68. Nicholson NS, Panzer-Knodle SG, Haas NF, et al. Assessment of platelet function assays. Am Heart J 1998;135(5 Pt 2 Suppl):S170-S178
69. Santos MT, Valles J, Marcus AJ, et al. Enhancement of platelet reactivity and modulation of eicosanoid production by intact erythrocytes. A new approach to platelet activation and recruitment. J Clin Invest 1991;87:571-580
70. Valles J, Santos MT, Aznar J, et al. Erythrocyte promotion of platelet reactivity decreases the effectiveness of aspirin as an antithrombotic therapeutic modality: the effect of low-dose aspirin is less than optimal in patients with vascular disease due to prothrombotic effects of erythrocytes on platelet reactivity. Circulation 1998;97:350-355 (Pubitemid 28074335)
71. Patrignani P. Aspirin insensitive eicosanoid biosynthesis in cardiovascular disease. Thromb Res 2003;110:281-286 (Pubitemid 37329826)
72. Favaloro EJ. Clinical utility of the PFA-100. Semin Thromb Hemost 2008;34:709-733
73. Michelson AD. Platelet function testing in cardiovascular diseases. Circulation 2004;110:e489-e493
74. Dyszkiewicz-Korpanty A, Olteanu H, Frenkel EP, Sarode R. Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100). Platelets 2007;18:491-496 (Pubitemid 350034851)
75. Ivandic BT, Schlick P, Staritz P, Kurz K, Katus HA, Giannitsis E. Determination of clopidogrel resistance by whole blood platelet aggregometry and inhibitors of the P2Y12 receptor. Clin Chem 2006;52:383-388 (Pubitemid 43306460)
76. Angiolillo DJ, Fernández-Ortiz A, Bernardo E, et al. High clopidogrel loading dose during coronary stenting: effects on drug response and interindividual variability. Eur Heart J 2004;25:1903-1910 (Pubitemid 39452607)
77. Gurbel PA, Bliden KP, Hayes KM, Yoho JA, Herzog WR, Tantry US. The relation of dosing to clopidogrel responsiveness and the incidence of high post-treatment platelet aggregation in patients undergoing coronary stenting. J Am Coll Cardiol 2005;45:1392-1396
78. Siemens Healthcare Diagnostics Inc. Dade-Behring. Dade® PFA-100® Reagents. To aid in the detection of platelet dysfunction in citrated human whole blood. B4170 G20A U5734 (97) H/CS/R. Deerfield, IL: Siemens Healthcare Diagnostics Inc; 2007:5
79. Hochholzer W, Trenk D, Frundi D, Neumann FJ. Whole blood aggregometry for evaluation of the antiplatelet effects of clopidogrel. Thromb Res 2007;119:285-291 (Pubitemid 44918096)
80. Sibbing D, Braun S, Jawansky S, et al. Assessment of ADP-induced platelet aggregation with light transmission aggregometry and multiple electrode platelet aggregometry before and after clopidogrel treatment. Thromb Haemost 2008;99:121-126
81. Tóth O, Calatzis A, Penz S, Losonczy H, Siess W. Multiple electrode aggregometry: a new device to measure platelet aggregation in whole blood. Thromb Haemost 2006;96:781-788 (Pubitemid 44883819)
82. Seyfert UT, Haubelt H, Vogt A, Hellstern P. Variables influencing Multiplate(TM) whole blood impedance platelet aggregometry and turbidimetric platelet aggregation in healthy individuals. Platelets 2007;18:199-206 (Pubitemid 46744118)
83. Penz SM, Reininger AJ, Toth O,Deckmyn H, Brandl R, Siess W. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques. Thromb Haemost 2007;97:435-443 (Pubitemid 46437806)
84. Mueller T, Dieplinger B, Poelz W, Calatzis A, Haltmayer M. Utility of whole blood impedance aggregometry for the assessment of clopidogrel action using the novel Multiplate analyzer - comparison with two flow cytometric methods. Thromb Res 2007;121:249-258 (Pubitemid 350148206)
85. Mueller T, Dieplinger B, Poelz W, Haltmayer M. Utility of the PFA-100® instrument and the novel multiplate analyzer for the assessment of aspirin and clopidogrel effects on platelet function in patients with cardiovascular disease. Clin Appl Thromb Hemost 2008; September 19 (Epub ahead of print)
86. Michelson AD, Cattaneo M, Eikelboom JW, et al; Platelet Physiology Subcommittee of the Scientific and Standardization Committee of the International Society on Thrombosis and HaemostasisWorking Group on Aspirin Resistance. Aspirin resistance: position paper of the Working Group on Aspirin Resistance. J Thromb Haemost 2005;3:1309-1311
87. Frenkel EP, Mammen EF. Sticky platelet syndrome and thrombocythemia. Hematol Oncol Clin North Am 2003;17:63-83
88. Mühlfeld AS, Ketteler M, Schwamborn K, et al. Sticky platelet syndrome: an underrecognized cause of graft dysfunction and thromboembolic complications in renal transplant recipients. Am J Transplant 2007;7:1865-1868 (Pubitemid 46905426)
89. Hackam DG, Eikelboom JW. Antithrombotic treatment for peripheral arterial disease. Heart 2007;93:303-308 (Pubitemid 46579516)
90. Mackie IJ, Bihari D, Machin SJ. Increased platelet aggregability in native whole blood in the adult respiratory distress syndrome (ARDS). Thromb Haemost 1987;58:1676; [abstract]
91. Jones RJ, Delamothe AP, Curtis LD, Machin SJ, Betteridge DJ. Measurement of platelet aggregation in diabetics using the new electronic platelet aggregometer. Diabet Med 1985;2:105-109
92. Mandal S, Sarode R, Dash S, Dash RJ. Hyperaggregation of platelets detected by whole blood platelet aggregometry in newly diagnosed noninsulin-dependent diabetes mellitus. Am J Clin Pathol 1993;100:103-107 (Pubitemid 23251875)
93. Schinco PC, Fusaro A, Marranca R, et al. Paraproteinaemias and platelet aggregation: role of whole blood aggregometry. Thromb Res 1989;55:267-277 (Pubitemid 19209315)